Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02436876 · ClinicalTrials.gov registry record · Phase 2
Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites
A Phase 2 study of Bacterial Infection, sponsored by Microbion Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
- 6
- Study locations
NCT02436876 is a Phase 2 study of Bacterial Infection that has completed, run by Microbion Corporation. The registered enrollment target is 29 participants, below the 102-participant average among 8 other Bacterial Infection trials with a reported enrollment target (72% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT02436876, a Phase 2 study of Bacterial Infection, has completed, sponsored by Microbion Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study evaluates the safety and clinical benefit of MBN-101 administered intraoperatively to osteosynthesis or osteomyelitis sites for patients diagnosed with an orthopedic infection, with or without orthopaedic hardware. Three quarters of the patients will receive MBN-101, while the other one quarter will receive placebo.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG MBN-101
Study Locations (6)
California
- Orthopedic Trauma Institute, University of California San Francisco - San Francisco
- UCSF - Parnassus - San Francisco
Maryland
- LifeBridge Health, Inc. - Baltimore
Ohio
- OhioHealth Research Institute - Columbus
Pennsylvania
- University of Pennsylvania - Philadelphia
Texas
- The University of Texas - Health Science Center & Medical School at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2016-05-24 |
| Est. Completion | 2018-07-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02436876
The ClinicalTrials.gov registry entry for NCT02436876 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 102-participant average among 8 other Bacterial Infection trials with a reported enrollment target (72% lower). The listed sponsor is Microbion Corporation, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacterial Infection appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02436876 reports 6 study locations spanning 5 distinct geographic areas - top geographies include California, Maryland, Ohio.
Frequently Asked Questions
What is clinical trial NCT02436876 about?
NCT02436876 is a clinical study titled "Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites". This study evaluates the safety and clinical benefit of MBN-101 administered intraoperatively to osteosynthesis or osteomyelitis sites for patients diagnosed with an orthopedic infection, with or without orthopaedic hardware. Three quarters of the patients will receive MBN-101, while the other one q...
What is the current status of trial NCT02436876?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2016-05-24. Estimated completion is 2018-07-26.
What conditions does trial NCT02436876 study?
This clinical trial studies the following conditions: Bacterial Infection.
What interventions are being tested in trial NCT02436876?
The interventions under investigation include: Placebo (OTHER), MBN-101 (DRUG).
Who is sponsoring clinical trial NCT02436876?
This trial is sponsored by Microbion Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02436876 being conducted?
This trial has 6 study locations across California, Maryland, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
COMPLETED · Phase 2
-
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
COMPLETED · Phase 2
-
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
RECRUITING · Phase 4
-
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
RECRUITING · Phase 4
-
Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm
COMPLETED · NA
-
Safety of Intravenous Apramycin in Adults
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.